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Summary
BACKGROUND: Patients with heart failure and reduced
ejection fraction (HFrEF) are at-risk for arrhythmic events.
The aetiology corresponds to incidence of sudden cardiac
death and effectiveness of shock therapy. We aimed to in-
vestigate repolarisation patterns in HFrEF patients with is-
chaemic (ICMP) or nonischaemic dilated cardiomyopathy
(DCMP) using high-resolution 65-lead surface electrocar-
diography.
METHODS: Fifty-six patients with heart failure underwent
coronary angiography and were treated with optimised
heart failure medication. Forty-two patients (13 female,
mean age 65.1 ± 10.7 years, left ventricular ejection frac-
tion 22.5 ± 6.5%) were then further stratified according to
QRS duration (n = narrow QRS complex <120 ms; w =
wide QRS complex >120 ms). Patients were divided into
four groups: wICMP, n = 12; nICMP, n = 10; wDCMP: n =
10; nDCMP: n = 10. Using a high-resolution electrocardio-
gram we estimated measures of parameters of transmural
dispersion of repolarisation.
RESULTS: At baseline, groups were comparable except
for variables related to group distribution. No difference in
heart rate or T wave duration could be detected. Howev-
er, the Tpeak-Tend interval differed significantly between
groups (nICMP vs wICMP: p = 0.030; nDCMP vs wDCMP:
p <0.001), and also in nICMP vs nDCMP (p = 0.021).
If DCMP and ICMP were grouped regardless of QRS
width, the Tpeak-Tend interval also differed significantly (p
= 0.035). Follow-up of 10 years revealed no difference be-
tween Tpeak-Tend interval, QRS-duration or aetiology of
heart failure in a combined endpoint of death, ventricular
arrhythmia or implantable cardioverter defibrillator therapy.
However, there was a significant difference for death be-
tween ICMP (n = 4, 19% vs DCMP (n = 0, 0%; p = 0.045).
CONCLUSION: ICMP had a longer Tpeak-Tend duration
and Tpeak-Ten -integral compared with DCMP despite
normal parameters of depolarisation (QRS duration/inte-
gral). This may reflect different arrhythmogenic morpho-
logical substrates and explain why ventricular tachycar-
dias are more common in ICMP.
Keywords: ischaemic cardiomyopathy, dilated cardiomy-
opathy, dispersion of repolarisation, sudden cardiac death
Introduction
Cardiovascular diseases are responsible for more than 30%
of deaths worldwide and among these about 25% are sud-
den cardiac deaths (SCDs) [1, 2]. Coronary artery disease
accounts for a large proportion of SCDs, especially in pa-
tients older than 40 years, mainly because of the acute
development of malignant arrhythmias during or immedi-
ately after physical exercise, probably due to ischaemic
triggers [3]. However, 10% of cases of SCD are associated
with cardiomyopathies of other aetiologies. It has been
postulated that arrhythmias possibly arise from the syner-
getic activation of the sympathetic nervous and renin-an-
giotensin systems acting on a sensitised underlying me-
chanical substrate and leading to disorganised electrical
activity, resulting in malignant arrhythmias and SCD. In
both ischaemic and nonischaemic cardiomyopathies, fibro-
sis and myocardial scars have been identified as a substrate
for adverse arrhythmic events. In contrast to scar-related
macro-reentrant ventricular tachycardia in ischaemic car-
diomyopathy, the mechanisms of arrhythmias in patients
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ECG repolarisation indices have repeatedly been the focus
for prediction of malignant ventricular arrhythmias and
SCD [5]. There is preliminary evidence that a prolongation
of transmural dispersion of repolarisation is independently
linked with an increased risk of ventricular arrhythmia and
SCD in patients with either ischaemic or nonischaemic car-
diomyopathies, as well as in the general population [6,
7] However, most ECG-derived analysis of parameters of
the transmural dispersion of ventricular repolarisation have
been carried out using the standard 12-lead surface ECG
with a focus at the anterior wall (lead V5) [8]. Therefore,
more comprehensive changes of repolarisation may have
been previously missed. To address this uncertainty, we
compared parameters of transmural dispersion of repolar-
isation in patients with ischaemic and nonischaemic car-




Patients previously diagnosed with cardiomyopathy due to
coronary artery disease (ICMP) or with cardiomyopathy of
nonischaemic origin (DCMP) and who underwent a regu-
lar follow-up in our outpatient clinic were included in this
study in 2001. These patients were eligible if they were
aged between 18 and 80 years, and had a left ventricular
ejection fraction (LVEF) of <35%, measured either inva-
sively (laevocardiography) or noninvasively (e.g., echocar-
diography, magnetic resonance imaging). Patients who
were pacemaker-dependent, presented with bundle branch
block and/or suffered from atrial fibrillation were exclud-
ed. The study was conducted according to the Declaration
of Helsinki and was approved by the local research ethics
committee. Written informed consent was obtained from
all participants. For follow-up, we consulted the digital pa-
tient charts in June 2019. Here we assessed the last fol-
low-up visit where the patient was alive, the date and cause
of death and if the patients had cardiac arrhythmias or im-
plantable cardioverter defibrillator (ICD) therapies. Rele-
vant cardiac arrhythmias were defined as definitive ven-
tricular arrhythmia and sub-grouped into sustained (>30
seconds) or nonsustained (<30 seconds) ventricular tachy-
cardia. ICD therapies were assessed by reviewing ICD in-
terrogation documents and ICD therapy was defined as an-
titachycardia pacing and/or adequate shock.
Study design
Electrocardiographic data recording
In order to eliminate any electromagnetic interference in
the investigation room, all electrical devices were switched
off. The room was silent. The room temperature was set
at the same level for all measurements and the lights were
turned off. All measurements were performed between
13:00 and 16:00. Patients were asked to abstain from to-
bacco, caffeine or alcohol intake on the day of the study.
A high-resolution 65-lead body-surface ECG was recorded
for each patient with a computer-based recording and
analysis system (Biosemi V.O.F., The Netherlands) [9, 10].
In total, 14 vertical self-adhesive straps with 65 unipolar
electrodes were placed on the patient’s torso as shown
in figure 1, starting from the vertebral column with the
patient in the sitting position. The other electrodes were
added with the patient lying down in a recumbent position.
Four electrodes were placed on the extremities according
to Einthoven. The electrodes D5, E5, F6, G6, H6 and I6
Figure 1: A high-resolution 65-lead body-surface ECG was recorded for each patient with a computer-based recording and analysis system
(Biosemi V.O.F., The Netherlands). Fourteen vertical self-adhesive straps with 65 electrodes were placed on the patient’s torso, as shown in
this figure, starting from the vertebral column with the patient in the sitting position. The other electrodes were added with the patient lying
down in a recumbent position. Four electrodes were placed on the extremities according to Einthoven. The electrodes D5, E5, F6, G6, H6 and
I6 were placed according to Wilson’s leads (where electrode “D5” was equivalent to Wilson’s “V1”).
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were placed according to Wilson’s leads (where electrode
“D5” was equivalent to Wilson's “V1”), as previously de-
scribed [10].
After patients had been lying for 5 minutes in a relaxed
supine position, recordings were started and continued for
at least 30 seconds. In patients with a cardiac device, the
device was switched off after all the leads had been at-
tached. After 90 seconds the signal was measured. Lead
placement was optimised until all leads produced an ac-
ceptable signal. If we were unable to reduce the noise in all
leads, we accepted a maximum number of 5–7 leads with
noise (i.e., 10%). We used 10 seconds of recording and
analysed three heart cycles. All measurements were per-
formed by one observer.
Measurements of systolic left ventricular function
Echocardiographic measurements were made by experi-
enced cardiologists and were performed within 3 months
from study beginning. LVEF was determined with the bi-
plane Simpson’s method. In every patient, coronary an-
giography had previously been performed in order to diag-
nose or rule out underlying coronary artery disease.
Data analysis
Details on the analysis, processing and calculation of the
65-lead ECG data are provided elsewhere [10]. As the
presence of bundle branch block (and consequently a nar-
row or wide QRS complex) obviously influences repo-
larisation patterns, we grouped our subjects according to
the width of the QRS complex: wide (>120ms) or narrow
(<120ms). Thereafter we compared patients with is-
chaemic and nonischaemic cardiomyopathy, resulting in
four groups. The following parameters were assessed in
all four groups: QRS duration, QRS integral, RR interval,
QTc duration, JT duration, JT integral, Tpeak-Tend dura-
tion, Tpeak-Tend integral.
QRS duration was determined from the beginning of the
QRS complex to the J point. The onset of QRS, J point and
offset of the T wave were identified manually from the root
mean square (RMS) signal. The QTc was calculated using
Bazett’s formula. The peak of the T wave was computed
as the maximum RMS signal voltage of the ST-T interval
where the RMS signal had the maximum value. RMS and
the area under QRS complex, JT integral and Tpeak-Tend
interval (integral) were calculated. Multiple measurements
of the parameters were made and mean values were used
for statistical analysis. If the onset or offset of a parame-
ter was not clear in the RMS graph, callipers were adjusted
according to the adjacent leads on the torso.
All data were analysed and processed off-line by the sig-
nal-processing tool ViewEDF, developed by UMIT (Uni-
versity for Health Informatics and Technology Tyrol, In-
stitute for Medical Signal Processing and Imaging; Hall,
Austria).
The RMS was calculated according to the formula below
(figure 2) from all 65 leads using Matlab software 6.0
(The MathWorks, Inc., Natick, MA); leads with poor sig-
nal quality were excluded.
Statistical analysis
Statistical analysis was performed with GraphPad InStat
version 3.06 for Windows, San Diego, California, USA
Figure 2: RMS calculation. N = number of analysed channels, vi =
voltage [mV] of lead i.
and SPSS, 2010, SPSS 18.0.2 for Windows, SPSS Inc.,
Armonk, NY, USA. Data are presented as mean (± stan-
dard deviation [SD]) and percentages, as appropriate. Cor-
relations between quantitative variables were calculated by
standard linear regression analysis. Differences in base-
line characteristics and comparisons of changes between
groups were assessed by paired or independent t-tests, as
appropriate. Categorical data were compared using the chi-
square test. A two-sided p-value of <0.05 was considered
to be statistically significant.
Results
Population
Forty-two patients were included and categorised into four
groups depending on the aetiology of cardiomyopathy and
QRS complex width (measured on 12-lead surface ECG).
The groups were defined as follows: patients with is-
chaemic cardiomyopathy and a narrow QRS <120 ms
(nICMP); patients with ischaemic cardiomyopathy and a
wide QRS >120 ms (wICMP,); patients with nonischaemic
cardiomyopathy and a narrow QRS <120 ms (nDCMP);
and patients with nonischaemic cardiomyopathy and a
wide QRS >120 ms (wDCMP). Examples of 12-lead sur-
face ECGs from each of the four groups are shown in fig-
ure 3. Baseline characteristics are summarised in table 1. In
total, 56 patients were screened, 14 patients were excluded
because of pacemaker dependency, atrial fibrillation and/
or transient bundle branch block. Subjects with cardiac re-
synchronisation therapy or a pacemaker were investigated
in intrinsic sinus rhythm. Subjects where then allocated to
the four prespecified groups.
In this observational study we found that, if matched for
the aetiology of the underlying cardiomyopathy, patients
with a wide QRS complex >120 ms had a statistically sig-
nificantly longer Tpeak-Tend interval and Tpeak-Tend in-
tegral compared with those with a narrow QRS complex
(wICMP vs nICMP, p = 0.03; wDCMP vs nDCMP, p
<0.001). Interestingly, patients with ischaemic cardiomy-
opathy and a narrow QRS complex also had a statistically
significantly longer Tpeak-Tend interval and Tpeak-Tend-
integral than patients with a narrow QRS complex and
nonischaemic cardiomyopathy (nICMP vs nDCMP,
p<0.001). However, irrespective of underlying cardiomy-
opathy both groups with widened a QRS complex >120ms
showed evidence of prolonged parameters of transmural
dispersion of repolarisation (p = 0.816). Electrocardio-
graphic characteristics are summarised in table 2.
Arrhythmogenic events were recorded after a mean follow-
up of 10 years for 40 patients out of 42 (95%). Arrhyth-
mogenic events were recorded after a mean follow-up of
10 years for 40 patients out of 42 (95%). In total, 13 pa-
tients (31%) had any documented arrhythmia of ventricu-
lar origin, therapy from an implanted defibrillator or death.
In total, 11 patients experienced ventricular tachycardia (9
Original article Cardiovasc Med. 2020;23:w02129
Cardiovascular Medicine · PDF of the online version · www.cardiovascmed.ch
Published under the copyright license “Attribution – Non-Commercial – No Derivatives 4.0”.
No commercial reuse without permission. See http://emh.ch/en/services/permissions.html.
Page 3 of 7
non-sustained ventricular tachycardia, 6 sustained ventric-
ular tachycardia; 4 patients had both sustained and non-
sustained ventricular tachycardia). Furthermore, 6 patients
received a therapy from an implanted defibrillator, and
4 patients died. As outcomes overlapped (i.e. a patient had
ICD-therapies prior to death), the numbers do not add up to
the sum of 13.No differences for the combined endpoint of
ventricular arrhythmia, ICD therapy or death were found
with respect to QRS duration, Tpeak-Tend interval and ae-
tiology of cardiomyopathy. However, a statistically signif-
icant difference for death in patients with ischaemic car-
diomyopathy as compared with those with nonischaemic
cardiomyopathy was observed (p = 0.045, 4, 19% vs 0,
0%).
Figure 3: Examples of 12-lead surface ECGs of the four groups: patients with ischaemic cardiomyopathy and narrow a QRS <120 ms
(nICMP); patients with ischaemic cardiomyopathy and a wide QRS >120 ms (wICMP); patients with nonischaemic cardiomyopathy and a nar-
row QRS <120 ms (nDCMP); and patients with nonischaemic cardiomyopathy and a wide QRS >120 ms (wDCMP).









Age (years) 65 ± 10.5 69 ± 4.8 57 ± 12.8 68 ± 11
Male (%) 60 83 70 60
LVEF (%) 25 ± 5 22 ± 7 25 ± 6 21 ± 6
CRT/PM (n) 1/0 6/3 1/0 6/4
ICD 3 4 0 3
Beta-blockers 2/10 9/12 6/10 8/10
Diuretics 2/10 10/12 3/10 7/10
ACE inhibitors / sartans 1/10 9/12 7/10 8/10
Amiodarone 4/10 4/12 2/10 0
Spironolactone 3/10 3/12 0 5/10
ACE = angiotensin converting-enzyme; CRT/PM = cardiac resynchronisation therapy/pacemaker; ICD = implantable cardioverter defibrillator; LVEF = left ventricular ejection frac-
tion. Values are mean ± standard deviation or percent as appropriate; p >0.05 for all comparisons.



















QRS duration (ms) 104 ± 11 163 ± 24 103 ± 12 170 ± 20 p <0.05 n.s. p <0.05 p <0.05 p <0.05
QRS integral 30 ± 14 79 ± 31 34 ± 13 87 ± 22 P <0.05 n.s. p <0.05 p <0.05 p <0.05
JT duration (ms) 301 ± 34 303 ± 52 295 ± 55 269 ± 30 n.s. n.s. p <0.05 p <0.05 p <0.05
T duration (ms) 302 ± 29 303 ± 52 295 ± 55 269 ± 30 n.s. n.s. p <0.05 n.s. n.s.
T integral 30 ± 9 73 ± 29 30 ± 15 76 ± 28 p <0.05 n.s. p <0.05 p <0.05 p <0.05
Tp-Te interval (ms) 109 ± 10 124 ± 19 76 ± 7& 126 ± 20 p <0.05 p <0.05 p <0.05 p <0.05 p <0.05
Tp-Te integral 10 ± 4 24 ± 11 7 ± 3 30 ± 16 p <0.05 n.s. p <0.05 p <0.05 p <0.05
QTc duration (ms) 438 ± 50 488 ± 45 412 ± 40 470 ± 47 p <0.05 n.s. n.s. p <0.05 p <0.05
Heart rate /min 73 ± 19 68 ± 16 70 ± 29 70 ± 12 n.s. n.s. n.s. n.s. n.s.
nICMP = ischaemic cardiomyopathy with normal QRS complex; wICMP = ischaemic cardiomyopathy with widened QRS complex; nDCMP = dilated cardiomyopathy with normal
QRS complex; wDCMP = dilated cardiomyopathy with widened QRS complex; Tp-Te = Tpeak to Tend Values are mean ± standard deviation.
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Discussion
It is of prognostic and therapeutic relevance to be able
to distinguish between ischaemic and nonischaemic car-
diomyopathy, particularly as SCD is one of the leading
causes of death in patients with ischaemic cardiomyopathy.
To date, several noninvasive markers have been considered
for risk stratification. Recent data from the DANISH trial
suggested that ischemic cardiomyopathy patients might in
general benefit from wider use of ICD therapy, whereas
only subgroups of nonischaemic cardiomyopathy patients
showed beneficial effects [11].
There is growing evidence that an increase in dispersion
of ventricular repolarisation, as reflected by the Tpeak-
Tend interval, represents a more reliable independent pre-
dictor for malignant arrhythmias compared to QTc time in
patients with Brugada syndrome, hypertrophic cardiomy-
opathy, heart failure with preserved ejection fraction (HF-
pEF), long QT syndrome and ischaemic cardiomyopathy
[12–17]. In “in vitro experiments”, Tpeak-Tend has been
established to be a measure of transmural dispersion of re-
polarisation due to a gradient in action potential duration
from endocardial cells to epicardial and to midmyocardial
M-cells [18, 19] [20]. Lately, the Tpeak-Tend interval has
rather been suggested as an index of overall global het-
erogeneity of ventricular repolarisation across the three di-
mensions of the intact heart in vivo [21, 22].
However, amplification of the dispersion of ventricular re-
polarisation has long been known as a favourable electro-
physiological substrate for the onset of malignant re-entry
arrhythmias. The combination of unfavourable mechanical
and electrical remodelling has been hypothesised on the
basis of findings in isolated wedge preparations of failing
human hearts, and impaired contractility has been related
to alterations of transmural dispersion of repolarisation and
impaired calcium handling across the different transmur-
al layers. This effect has also been demonstrated in a ran-
domised controlled trial, in which alteration in the disper-
sion of repolarisation has been positively associated with
mechanical wall stress during obstructive apnoea [23, 24].
In our study we postulated the existence of different me-
chanical substrates due to either ischaemic or nonis-
chaemic heart disease. We demonstrated an association of
repolarisation abnormalities by analysing different para-
meters of transmural dispersion of repolarisation using a
65-lead ECG, which allowed more reliable calculations by
limiting systematic errors due to unclear T wave offset [9].
We found that patients with coronary artery disease had a
significantly prolonged Tpeak-Tend duration and Tpeak-
Tend integral compared with patients with cardiomyopathy
from other causes, despite normal parameters of depolari-
sation.
In a prospective study including 1570 patients with heart
failure due to both dilated and ischaemic cardiomyopathy
(mean LVEF 32% and 44%, respectively), Tpeak-Tend du-
ration was found to be significantly longer in those who
experienced SCD or appropriate cardioverter defibrillator
discharge compared with healthy controls. However, this
trial failed to find a prognostic value of prolongation in
dispersion of repolarisation, possibly owing to a relatively
preserved ejection fraction, indicating a not yet deranged
mechanical ventricular remodelling [25]. In contrast, in an-
other clinical study with a similar population but with a
mean LVEF of 23%, a longer Tpeak-Tend interval mea-
sured during spontaneous rhythm predicted the onset of
malignant arrhythmia as well as an increased overall mor-
tality, even after correction for other independent predic-
tors [26]. Recently, in a large prospective study including
more than 138,000 individuals older than 50 years pre-
senting to primary care, a U-shaped association between
Tpeak-Tend duration and the risk of all-cause mortality,
cardiovascular death and heart failure was found [27].
These findings have been confirmed in a recent meta-
analysis analysing risk of SCD from 33 prospective and
retrospective studies. A prolonged Tpeak-Tend interval
was found to be associated with a 1.14-fold higher risk of
SCD or malignant ventricular arrhythmia independently of
characteristics of the populations [28].
In our small study, we found a statistically significant in-
crease in parameters of dispersion of repolarisation in pa-
tients with heart failure due to ischaemic heart disease,
regardless of alterations in depolarisation as defined by
QRS width. This finding may reflect a specific arrhyth-
mogenic morphological substrate attributable to ischaemic
cardiomyopathy. Several animal studies have tried to ad-
dress this hypothesis. In a porcine model of myocardial in-
farction, acute ischaemia resulted in an increase in disper-
sion of repolarisation and was postulated to contribute to
ventricular fibrillation, possibly by facilitating the onset of
a unidirectional conduction block [29]. In another animal
model, Tpeak-Tend duration strongly correlated with the
invasively measured increase in ventricular dispersion of
repolarisation caused by bilateral sympathetic nerve stim-
ulation [30]. Therefore, this may directly reflect increased
sympathetic nerve activation, a common condition after
myocardial infarction, possibly leading to SCD [31]. Fur-
ther studies suggested that measurement of Tpeak-Tend in-
terval seems to be an appropriate tool for arrhythmogenic
risk stratification in patients who suffered acute myocar-
dial ischaemia even after successful reperfusion treatment.
This increased risk may also be increased due to a post-is-
chaemic disadaptive chronic activation of the sympathet-
ic nervous system [32–34]. This could be one reason why
patients with heart failure due to ischaemic cardiomyopa-
thy are at higher risk for ventricular arrhythmias than a
matched population with heart failure due to other caus-
es, despite having no signs of ventricular remodelling (like,
for example, bundle branch block).
Not surprisingly, we found that a QRS duration >120ms
was related to an increase in parameters of dispersion of re-
polarisation independently of the aetiology of heart failure.
Cardiac dyssynchrony is a known unfavourable prognostic
factor in heart failure and resynchronisation therapy is, by
now, a well-established therapy with a high level of recom-
mendation for these patients [35]. There is also evidence
regarding a beneficial effect of resynchronisation thera-
py on dispersion of ventricular repolarisation [36]. In is-
chaemic and nonischaemic patients, QRS widening due to
QRS fragmentation indicated a worse prognosis and may
reflect electromechanical remodelling due to myocardial
scarring [25, 37].
We found a significant increase in mortality in patients
with ischaemic cardiomyopathy as compared with patients
with dilated cardiomyopathy. In line with the DANISH
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trial, which showed that in dilated cardiomyopathy ICDs
were not associated with a significantly lower long-term
rate of death from any cause than was usual clinical care
[38], our results also indicate that the ischaemic cause of
heart failure is especially vulnerable to arrhythmic events.
No differences were found, however, based on QRS dura-
tion. This might be explained by the small size of our pop-
ulation.
The Tpeak-Tend interval helps to identify these detrimen-
tal myocardial and electrical remodelling effects indepen-
dently of the underlying aetiology. Therefore, measure-
ment of Tpeak-Tend interval may help to further improve
risk stratification on an individual basis.
Some confounding factors must be considered. Firstly, this
was a small observational study with limited data, and un-
known confounders related to a small sample size might
have influenced the results. Furthermore, we did not have
data on myocardial scaring (cardiac magnetic resonance
imaging or voltage maps from invasive electrophysiologi-
cal studies).The percentage of atrial, right and left ventric-
ular pacing before the 65-lead ECG had not been record-
ed. Also, several methodological limitations also apply.
We used a standardised protocol for the application of the
vertical electrode strips; however, slight variability due to
body size and shape are possible. Confounding of T wave
memory might apply to our patients with cardiac devices.
Because of time restraints and also the safety of the pa-
tients, we refrained from waiting longer with a deactivated
device. We therefore cannot rule out some T wave memory
effects that might have confounded our results.
However, the strength of the study was the very long fol-
low up. The identification of the T wave offset was some-
times problematic, which may have resulted in intraob-
server and interobserver variability. To adjust for this
limitation multiple measurements were performed and av-
erage values were used for statistical analysis.
Finally, there is a circadian variability in both depolari-
sation and repolarisation characteristics. Measurements in
our study were performed in the early afternoon on a rou-
tinely basis.
Conclusion
In this study we analysed different parameters of the trans-
mural dispersion of repolarisation by using a high-resolu-
tion 65-lead ECG, which allowed more reliable calcula-
tions by reducing systematic errors due to unclear T wave
offset. We found that patients with ischaemic heart failure
show statistically significant prolonged Tpeak-Tend du-
ration and Tpeak-Tend integral values as compared with
nonischaemic heart failure patients, despite normal para-
meters of depolarisation. This may reflect the different ar-
rhythmogenic morphological substrate, and explain why
ventricular tachycardia is much more common in is-
chaemic cardiomyopathy. These data may provide further
evidence for the detection and stratification of patients who
could benefit from prophylactic implantation of defibrilla-
tor.
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